Holen Sie sich die Stockscreener-App
158.83
0.86%
1.52
Schlusskurs vom Vortag:
$157.31
Offen:
$156.79
24-Stunden-Volumen:
275.52K
Relative Volume:
0.15
Marktkapitalisierung:
$9.09B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.26%
1M Leistung:
+9.91%
6M Leistung:
+25.35%
1J Leistung:
+13.10%
1-Tages-Spanne:
$156.00
$159.19
1-Wochen-Bereich:
$155.00
$159.19
52-Wochen-Spanne:
$107.43
$159.19
Ishares Biotechnology Etf Stock (IBB) Company Profile
Firmenname
Ishares Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IBB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
158.78 | 9.09B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.67 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
682.95 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
686.29 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.47 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
631.71 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf Aktie (IBB) Neueste Nachrichten
Biotech ETFs Hovering Around a 52-Week: Here's Why - TradingView
Analyst Explains Why He’s Investing in This Top Biotech ETF - Insider Monkey
StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market - Genetic Engineering and Biotechnology News
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - sharewise.com
IBB: Biotech's Leading Players, All In One ETF (NASDAQ:IBB) - Seeking Alpha
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - sharewise.com
Biotech ETFs Bounce Back in 2025: Here's Why - TradingView
ISHARES TRUST (^IBB) stock price, news, quote and history - Yahoo
Should You Invest in the iShares Biotechnology ETF (IBB)? - MSN
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures - Benzinga
iShares TrustiShares Biotechnology ETF (IBB.SN) latest stock news and headlines - Yahoo
Enpro Moves To Boost Profits With $280 Million Acquisition Push - Benzinga
VanEck Biotech ETF (BBH): How to Buy - The Motley Fool
Destiny Wealth Sells $8.1 Million in IBB Shares — Here’s Why Biotech Stocks Are Lagging - The Motley Fool
How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline - Benzinga
SciSparc And AutoMax Call Off Merger - Sahm
iShares Biotechnology ETF (NQ: - FinancialContent
The Best Biotech ETFs to Buy - Kiplinger
How to Invest in the Entire Biotechnology Industry Through One ETF? - NAI500
Best Biotech ETFs to Watch Right Now - The Motley Fool
How to Invest in iShares Biotechnology ETF (IBB) - The Motley Fool
iShares Biotechnology ETF (IBB) Stock Price, News, Quote & History - Yahoo
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.0828 - MSN
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - sharewise.com
Biotech Sector May Flip to Market Leader by Year-End - MarketBeat
Trump's Biotech Playbook Ignites $350 Billion Investment Blitz - Benzinga
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.2005 - MSN
BBH vs. IBB: How to Position for the Next Biotech Growth Cycle - AInvest
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH (NASDAQ:IBB) - Seeking Alpha
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
(08/22/25) IBB and XBI: Are These Biotech ETFs Worth Trading Here? - moneyshow.com
Healthcare Stocks Move In Different Directions On Key News - Finimize
Bio-Techne Stock: Analyst Estimates & Ratings - NewsBreak: Local News & Alerts
The Longevity Dividend: How Financial Institutions Are Pioneering the Future of Retirement and Healthspan Investing - AInvest
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Solar, biotech, and health insurance stocks are moving on Friday: here's why - TheStreet
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
Biotech And Pharma Stocks Rally After Positive News And Upgrades - Finimize
ARKK Inflows Stay Hot - ETF.com
7 Best Biotech ETFs to Buy Now - US News Money
The Silver Dividend: Unlocking Longevity-Driven Investment Opportunities in Healthspan, AI, and Age-Friendly Infrastructure - AInvest
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - sharewise.com
The Silver Dividend: Strategic Investments in Longevity Technologies and Age-Friendly Sectors for 2025 and Beyond - AInvest
The Longevity Dividend: Investing in the Future of Healthspan Extension - AInvest
Unlocking the Longevity Dividend: Growth Stocks for the Age of Extended Lifespans - AInvest
BIO assets in stake since beginning, accumulating XP for token launch with $205,000 FDV. - AInvest
The Silver Dividend: How Aging Populations Can Drive Economic Growth and Longevity-Linked Investment Opportunities - AInvest
The Silent Crisis: Aging Populations and the Retirement Security Imperative - AInvest
Finanzdaten der Ishares Biotechnology Etf-Aktie (IBB)
Es liegen keine Finanzdaten für Ishares Biotechnology Etf (IBB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):